Researchers have identified a possible way to make glioblastoma cells vulnerable to different types of immunotherapy. The strategy, which they demonstrated in cells in the lab, forces brain cancer ...

MB-108 shows activity and is well tolerated in recurrent glioblastoma, with preclinical data supporting its combination with ...

Researchers from Queen Mary University of London, the Chinese Academy of Sciences and Capital Medical University in Beijing ...

Chen recommended a minimally invasive procedure that uses heat to target the remaining tumor cells. This technique, done in ...

In a cell-based study, researchers have forced glioblastoma cells to display immune system targets, making them visible to ...

Preclinical data has suggested that the combination therapy could potentially optimise outcomes for patients with recurrent ...

A cancer-killing virus has shown promise in tackling an aggressive type of brain tumour, researchers say. Certain viruses ...

Glioblastoma is the most common and fatal type of brain cancer, with most patients surviving fewer than 14 months after ...

"For example, CAR-T 19 targets CD19 on every B cell, but the EGF receptor mutations that we're targeting in glioblastoma are ...

MRI brain scans of one of the trial participants who achieved a complete response. See original paper for more details. © Ning, W. et al. 2024 CC-BY ...

The University of Texas MD Anderson Cancer Center today announced the launch of its Institute for Cell Therapy Discovery & Innovation, which will build upon longstanding MD Anderson clinical and ...

UC San Francisco treated its first brain cancer patient with an experimental new CAR-T therapy discovered and manufactured at ...